MCNULTY JAMES A enters INHIBITOR THERAPEUTICS, INC. with 86.18M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 12/22/2022ACC: 0000899243-22-039251
Officer10% Owner· See Remarks
Since Dec 2022
86.18M
Baseline shares
1% direct
548K
Direct ownership
1 position
150K
Derivative underlying
1 instrument
2
Security positions
85.63M indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned548K
Common Stock
IndirectShares owned85.63M
Total
548K direct·85.63M indirect86.18M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 548K | Direct |
| Common Stock | 85.63M | Indirect |
| Total | 86.18M | 548K direct·85.63M indirect |
Derivative Holdings1
Options
DirectUnderlying security
Common Stock
Underlying shares
150K
Shares owned
N/A
Exercise price
0.24
Expiration
—
Exercise window
—
Total
Underlying
150K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options Direct | Common Stock | 0.24 | — | — | 150K | N/A |
| Total | 150K | 0.00 | ||||